Dosage trial of a combination of oxamniquine and praziquantel in the treatment of Schistosomiasis in Zimbabwean school childrenCREASEY, A; TAYLOR, P; THOMAS, J et al.Central african journal of medicine. 1986, Vol 32, Num 7, pp 165-167, issn 0008-9176Article

The proinflammatory cytokyne response to coagulation and endotoxin in whole bloodJOHNSON, K; AARDEN, L; CHOI, Y et al.Blood. 1996, Vol 87, Num 12, pp 5051-5060, issn 0006-4971Article

Maternal inheritance of extrachromosomal DNA in malaria parasitesCREASEY, A; MENDIS, K; CARLTON, J et al.Molecular and biochemical parasitology. 1994, Vol 65, Num 1, pp 95-98, issn 0166-6851Article

Soluble IL-2 receptor β and γ subunit: ligand binding and cooperativityJOHNSON, K; YOON CHOI; ZINING WU et al.European cytokine network (Montrouge). 1994, Vol 5, Num 1, pp 23-34, issn 1148-5493Article

Genetic diversity of Plasmodium Falciparum shows geographical variationCREASEY, A; FENTON, B; WALKER, A et al.The American journal of tropical medicine and hygiene. 1990, Vol 42, Num 5, pp 403-413, issn 0002-9637, 11 p.Article

Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severityCREASEY, A; GIHA, H; HAMAD, A. A et al.Parasitology (London. Print). 2004, Vol 129, pp 263-271, issn 0031-1820, 9 p., 3Article

Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitorJOHNSON, K; ZAROR, I; BAUER, D et al.Thrombosis and haemostasis. 1998, Vol 80, Num 4, pp 585-587, issn 0340-6245Article

Measurement of Plasmodium falciparum growth rates in vivo : A test of malaria vaccinesCHENG, Q; LAWRENCE, G; REED, C et al.The American journal of tropical medicine and hygiene. 1997, Vol 57, Num 4, pp 495-500, issn 0002-9637Article

Superimposing two-dimensional gels to study genetic variation in malaria parasitesHORGAN, G; CREASEY, A; FENTON, B et al.Electrophoresis (Weinheim. Print). 1992, Vol 13, Num 11, pp 871-875, issn 0173-0835Article

Application of a novel chemiluminescence-based DNA detection method to single-vector and multiplex DNA detection method to single-vector and multiplex DNA sequencingCREASEY, A; D'ANGIO, L. JR; SLATKO, B et al.BioTechniques. 1991, Vol 11, Num 1, pp 102-109, issn 0736-6205, 6 p.Article

Plasmodium falciparum: an abundant stage-specific protein expressed during early gametocyte developmentCARTER, R; GRAVES, P. M; CREASEY, A et al.Experimental parasitology. 1989, Vol 69, Num 2, pp 140-149, issn 0014-4894Article

A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicityCREASEY, A. A; YAMAMOTO, R; VITT, C. R et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 10, pp 3293-3297, issn 0027-8424Article

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factorCREASEY, A. A; REYNOLDS, M. T; LAIRD, W et al.Cancer research (Baltimore). 1986, Vol 46, Num 11, pp 5687-5690, issn 0008-5472Article

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factorCREASEY, A. A; REYNOLDS, M. T; LAIRD, W et al.Cancer research (Baltimore). 1986, Vol 46, Num 11, pp 5687-5690, issn 0008-5472Article

Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteinsCARLINO, J. A; LIN, L. S; CREASEY, A. A et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 3, pp 958-961, issn 0021-9258Article

Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14PARK, C. T; CREASEY, A. A; WRIGHT, S. D et al.Blood. 1997, Vol 89, Num 12, pp 4268-4274, issn 0006-4971Article

Binding of ¹²⁵I-labeled recombinant β interferon (IFN-β Ser₁₇) to human cellsÓROURKE, E. C; DRUMMOND, R. J; CREASEY, A. A et al.Molecular and cellular biology (Print). 1984, Vol 4, Num 12, pp 2745-2749, issn 0270-7306Article

Potency stability of recombinant (serine-17) human interferon-βGEIGERT, J; ZIEGLER, D. L; PANSCHAR, B. M et al.Journal of interferon research. 1987, Vol 7, Num 2, pp 203-211, issn 0197-8357Article

Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitisCAMEROTA, A. J; CREASEY, A. A; PATLA, V et al.The Journal of infectious diseases. 1998, Vol 177, Num 3, pp 668-676, issn 0022-1899Article

A serum factor that suppress the cytotoxic function of cytokine-stimulated human eosinophilsSILBERSTEIN, D. S; MINKOFF, M. S; CREASEY, A. A et al.The Journal of experimental medicine. 1990, Vol 171, Num 3, pp 681-693, issn 0022-1007Article

New potential therapeutic modalities : Tissue Factor Pathway InhibitorCREASEY, A. A.Sepsis (Boston). 1999, Vol 3, Num 2, pp 173-182, issn 1385-0229Article

Site-specific mutagenesis of the human fibroblast interferon geneMARK, D. F; LU, S. D; CREASEY, A. A et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 18, pp 5662-5666, issn 0273-1134Article

Cytostatic and cytolytic effects of human recombinant tumor necrosis factor on human renal cell carcinoma cell lines derived from a single surgical specimenHEICAPPELL, R; NAITO, S; ICHINOSE, Y et al.The Journal of immunology (1950). 1987, Vol 138, Num 5, pp 1634-1640, issn 0022-1767Article

Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. I : Diversity of enzymes, 2D-PAGE proteins and antigensHAMZA ALI BABIKER; CREASEY, A. M; FENTON, B et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1991, Vol 85, Num 5, pp 572-577, issn 0035-9203Article

Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorFENDLY, B. M; TOY, K. J; CREASEY, A. A et al.Hybridoma. 1987, Vol 6, Num 4, pp 359-370, issn 0272-457XArticle